GlaxoSmithKline reports a bird flu 'breakthrough'.
Glaxo believes that it has developed a vaccine effective against the H5N1 bird flu virus that's effective in small doses. Governments can order the vaccine for stockpiling in early 2007.
Posted by Jill Fallon at July 26, 2006 11:53 AM | TrackBack | Permalink